started · updated
Ozempic and Mounjaro may help preserve memory, study suggests
A scientific review published in the journal Science suggests that medications used to treat obesity and type 2 diabetes, such as Ozempic (semaglutide) and Mounjaro (tirzepatide), may contribute to preserving memory and other cognitive functions.
Researchers from the University of Gothenburg in Sweden and the University of Copenhagen in Denmark conducted the review, which examines the relationship between metabolism and brain function. The study analyzed animal experiments, observational studies, and clinical trials. While animal models showed that GLP-1 receptor agonists could influence learning and memory, human results remain less consistent.
Observational data from medical records have identified an association between these medications and a lower risk of dementia in individuals with type 2 diabetes. However, researchers emphasize that this does not prove causation, as other factors may influence the results. Furthermore, two large clinical trials, EVOKE and EVOKE+, found that semaglutide did not successfully slow the progression of early-stage Alzheimer's disease, despite changes in certain biological markers.
Entities
Mounjaro · Ozempic · Science · University of Copenhagen · University of Gothenburg